Selective culture changes the population that reaches the plate. This makes the performance of PFIZER Selective ENTEROCOCCUS Agar Culture Media inseparable from matrix, enrichment time, and confirmation design. The discussion below connects its documented role with preparation variables, controls, interpretation, and the limits of inference. Catalogue 610319 is discussed as a laboratory measurement component; implementation should follow the laboratory SOP and validated reference method.

Analytical scope and method role

PFIZER SELECTIVE ENTEROCOCCUS AGAR is a medium in powder used for the enumeration of fecal streptococci by membrane filtration method.

Method principle

Peptone, tryptone and yeast extract provide nitrogen and other nutrients necessary to support the bacterial growth. Bacteriological bile inhibits Gram-positive bacteria other than enterococci. Organisms positive for esculin hydrolysis hydrolyze the glycoside esculin to esculetin and dextrose. The esculetin reacts with the ferric citrate to form a dark brown or black complex. Sodium chloride keeps the osmotic balance of the medium. Sodium azide inhibits the bacterial flora grown during the preliminary test, except for enterococci. Sodium citrate is the buffer of the medium. Agar is the solidifying agent.

Formula and functional interpretation

(g/l) Peptone 3.3 Yeast extract 5.35 Tryptone 17.0 Bacteriological Bile 10.0 Esculine Hydrate 1.0 Ammonium Ferric Citrate 0.5 Sodium Chloride 5.0 Sodium azide 0.25 Sodium Citrate 1.0 Agar 14.0 pH finale 7.1 ± 0.2

Review the nutritive, selective, differential, buffering, reducing, and indicator components against the expected target and background flora. Preparation errors can change recovery, inhibition, colour development, or endpoint visibility even when incubation is correct.

Preparation and execution: controlled method points

Preparation: Suspend 58.0 g of powder into 1 liter of distilled or deionized water. Heat until completely dissolved. Autoclave at 121°C for 15 minutes. Dispense in petri dishes.

Procedure: Membrane Filtration Method Filter the suspension of the sample through a sterile membrane to give 20-200 colonies on the membrane surface. Transfer the membrane on the agar surface, invert the plates and incubate at 36+/-1°C for 18-48 hours.

Translate the method into controlled worksheet fields: catalogue and lot, preparation mass or volume, water quality, pH where applicable, heating or sterilization, supplements, dispense volume, preparation date, expiry assignment, incubation atmosphere and temperature, reading window, equipment, and analyst. Record departures as deviations instead of silently normalizing them.

Quality control: what the control result protects

Challenge both sides of performance. Include a target reaction demonstrating recovery and, when relevant, a non-target or alternate reaction challenging inhibition or differentiation. Record expected and observed responses, acceptance criteria, strain and passage, lot, incubation, and disposition. A failed control blocks result interpretation until the cause is resolved.

Interpretation and confirmation pathway

On the agar surface count all the brown-black colonies. Express the result as UFC (Units Forming Colonies) / 100 ml.

Record the raw observation before the conclusion: morphology or colour, growth pattern, endpoint, reaction intensity, reading time, and control response. Presumptive reactions remain presumptive. Route atypical, weak, mixed, or delayed reactions through the confirmation step in the current method.

Storage, stability, and pre-use inspection

CONDITIONS The powder is very hygroscopic: store the powder at 10-30°C, in a dry environment, in its original container tightly closed and use it before the expiry date on the label or until signs of deterioration or contamination are evident. Store prepared media at 2-8°C. WARNING AND PRECAUTION The product is not classified as hazardous by current legislation and does not contain harmful substances in concentrations of ≥1%. The product is designed for In vitro diagnostic use and must be used only by properly trained operators.

Receipt and storage records should reconstruct temperature exposure, lot rotation, expiry, container integrity, and time outside controlled storage. Inspect colour, clarity, fill volume, gel integrity, contamination, dehydration, and precipitate before use.

Limitations and boundaries of use

Applicability depends on matrix, target organism, interfering flora, inoculum, validated method, and regulatory setting. Do not transfer conditions or acceptance criteria from a different matrix without verification.

Troubleshooting from evidence, not guesswork

  • Poor recovery: check preparation, pH, overheating, supplement addition, inoculum, atmosphere, storage, and control performance.
  • Loss of selectivity: review formulation, sterilization, expiry, inoculum burden, enrichment sequence, and incubation time.
  • Weak or atypical reaction: confirm reading time and atmosphere, compare controls, document mixed growth, and follow confirmation requirements.
  • Run-to-run drift: trend lot, analyst, equipment, water, preparation batch, controls, and environmental conditions.

External method context

The product should be understood as one measurement component in an antimicrobial susceptibility method. The analytical chain includes isolate purity, standardized inoculum, medium composition, antimicrobial concentration, incubation atmosphere and time, endpoint reading, and the interpretive table selected by the laboratory. A shift in any upstream variable can move an MIC or zone without a change in organism biology, which is why QC distributions and trend review are more informative than a single pass/fail control.

External laboratory-quality guidance also supports a lifecycle view: verify the method when introduced, bridge new lots against an accepted lot, trend control results, investigate nonconformities, and retain enough raw observations to reconstruct the decision. This is the practical difference between reproducing a preparation instruction and demonstrating that the resulting measurement is fit for its intended use.

EUCAST disk diffusion and quality control

EUCAST requires standardized methodology, current breakpoint tables, and routine quality control; the laboratory remains responsible for the final susceptibility report. For broth dilution, inoculum density, cation content, pH, incubation atmosphere, endpoint definition, and two-fold dilution design influence MIC reproducibility. Breakpoints are interpretive rules applied after a technically valid MIC or zone measurement; they are not properties of the product alone. Review the authoritative source.

FDA Bacteriological Analytical Manual

FDA BAM methods organize food microbiology around validated sampling, preparation, enrichment, isolation, and confirmation steps, with method applicability tied to the matrix and target organism. Sampling uncertainty, homogenization efficiency, inhibitory ingredients, dilution design, and countable range can dominate the result before the culture medium is ever inoculated; those variables belong in method verification and uncertainty review. Review the authoritative source.

WHO Laboratory Quality Management System handbook

WHO laboratory quality guidance treats document control, equipment, purchasing and inventory, process control, records, occurrence management, and continual improvement as connected parts of reliable testing. Review the authoritative source.

Technical references

  1. Manufacturer product documentation for catalogue 610319.
  2. EUCAST disk diffusion and quality control (access checked 2026-07-20).
  3. FDA Bacteriological Analytical Manual (access checked 2026-07-20).
  4. WHO Laboratory Quality Management System handbook (access checked 2026-07-20).

Bench-use checklist

  • Verify product identity, catalogue number, lot, expiry, and storage history.
  • Document preparation and incubation exactly as controlled in the SOP.
  • Define controls and acceptance criteria before testing.
  • Record raw observations, control response, reading time, and confirmation decision.
  • Escalate failed controls, atypical reactions, and departures through the quality system.